These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 492618

  • 1. High-risk prematurity--progestin treatment and steroid studies.
    Johnson JW, Lee PA, Zachary AS, Calhoun S, Migeon CJ.
    Obstet Gynecol; 1979 Oct; 54(4):412-8. PubMed ID: 492618
    [Abstract] [Full Text] [Related]

  • 2. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
    Hartikainen-Sorri AL, Kauppila A, Tuimala R.
    Obstet Gynecol; 1980 Dec; 56(6):692-5. PubMed ID: 7443111
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor.
    Johnson JW, Austin KL, Jones GS, Davis GH, King TM.
    N Engl J Med; 1975 Oct 02; 293(14):675-80. PubMed ID: 1099445
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F, Vaccaro V.
    Minerva Ginecol; 2009 Oct 02; 61(5):401-9. PubMed ID: 19749671
    [Abstract] [Full Text] [Related]

  • 5. Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Meis PJ, Klebanoff M, Dombrowski MP, Sibai BM, Leindecker S, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S.
    Obstet Gynecol; 2005 Sep 02; 106(3):557-61. PubMed ID: 16135587
    [Abstract] [Full Text] [Related]

  • 6. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine.
    Kauppila A, Hartikainen-Sorri AL, Jänne O, Tuimala R, Järvinen PA.
    Am J Obstet Gynecol; 1980 Oct 15; 138(4):404-8. PubMed ID: 7424996
    [Abstract] [Full Text] [Related]

  • 7. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate.
    Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner BM, Kessler I, Lancet M.
    Am J Obstet Gynecol; 1985 Mar 01; 151(5):574-7. PubMed ID: 3976757
    [Abstract] [Full Text] [Related]

  • 8. Serum progesterone and estradiol in pregnant women selected for progestagen treatment.
    Dubin NH, Moszkowski EF, Kavoussi KM, Ward MM, Ances IG.
    Int J Fertil; 1979 Mar 01; 24(2):86-93. PubMed ID: 40914
    [Abstract] [Full Text] [Related]

  • 9. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.
    Spong CY, Meis PJ, Thom EA, Sibai B, Dombrowski MP, Moawad AH, Hauth JC, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S, National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network.
    Am J Obstet Gynecol; 2005 Sep 01; 193(3 Pt 2):1127-31. PubMed ID: 16157124
    [Abstract] [Full Text] [Related]

  • 10. 17 hydroxyprogesterone for the prevention of preterm delivery.
    Meis PJ, Society for Maternal-Fetal Medicine.
    Obstet Gynecol; 2005 May 01; 105(5 Pt 1):1128-35. PubMed ID: 15863556
    [Abstract] [Full Text] [Related]

  • 11. Prophylactic use of hydroxyprogesterone caproate in abdominal surgery during pregnancy. A retrospective evaluation.
    Hill LM, Johnson CE, Lee RA.
    Obstet Gynecol; 1975 Sep 01; 46(3):287-90. PubMed ID: 1161231
    [Abstract] [Full Text] [Related]

  • 12. Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
    How HY, Barton JR, Istwan NB, Rhea DJ, Stanziano GJ.
    Am J Obstet Gynecol; 2007 Sep 01; 197(3):260.e1-4. PubMed ID: 17826411
    [Abstract] [Full Text] [Related]

  • 13. Changes in the concentration of 17 alpha,20 alpha-dihydroxypregn-4-en-3-one during pregnancy, labor, and delivery and the effect of dexamethasone treatment during the third trimester of pregnancy.
    Mahajan DK, Anderson G, Poole WK, Billiar RB, Little B.
    J Clin Endocrinol Metab; 1983 Sep 01; 57(3):585-91. PubMed ID: 6874891
    [Abstract] [Full Text] [Related]

  • 14. Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins.
    Christian MS, Brent RL, Calda P.
    J Matern Fetal Neonatal Med; 2007 Feb 01; 20(2):89-112. PubMed ID: 17437208
    [Abstract] [Full Text] [Related]

  • 15. Quantitative changes in steroid and peptide hormones in the maternal-fetoplacental system between the 28th-40th weeks of pregnancy.
    Hercz P.
    Acta Med Hung; 1985 Feb 01; 42(1-2):29-39. PubMed ID: 4034335
    [Abstract] [Full Text] [Related]

  • 16. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
    Odibo AO, Stamilio DM, Macones GA, Polsky D.
    Obstet Gynecol; 2006 Sep 01; 108(3 Pt 1):492-9. PubMed ID: 16946206
    [Abstract] [Full Text] [Related]

  • 17. Multiple radioimmunological determinations of free (diffusible) steroid hormones (cortisol, progesterone, 17alpha OH-progesterone and estradiol) in the same plasma dialyzate after equilibrium dialysis.
    Clerico A, Del Chicca MG, Ferdeghini M, Mariani G.
    J Nucl Med Allied Sci; 1979 Sep 01; 23(3):145-7. PubMed ID: 549966
    [No Abstract] [Full Text] [Related]

  • 18. [Prematurity in multiple pregnancies].
    Krampl E, Klein K.
    Gynakol Geburtshilfliche Rundsch; 2007 Sep 01; 47(2):64-9. PubMed ID: 17440266
    [Abstract] [Full Text] [Related]

  • 19. Maternal plasma and amniotic fluid 17 beta-estradiol, progesterone and cortisol concentrations in women with successfully and unsuccessfully treated preterm labor.
    Mazor M, Hershkowitz R, Ghezzi F, Cohen J, Silber A, Levy J, Leiberman JR, Glezerman M.
    Arch Gynecol Obstet; 1996 Sep 01; 258(2):89-96. PubMed ID: 8779616
    [Abstract] [Full Text] [Related]

  • 20. The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage.
    Rebarber A, Cleary-Goldman J, Istwan NB, Rhea DJ, Desch C, Russo-Stieglitz K, Saltzman DH.
    Am J Perinatol; 2008 May 01; 25(5):271-5. PubMed ID: 18401840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.